As the ATPase activity of BRG1 is also vital to protecting and actively reversing epigenetic silencing of genes by polycomb repressor complexes (PRCs), its LOF appears to drive cancer via major epigenetic and transcriptional reprograming [18,19]. The gene discussed is SMARCA4; the disease is cancer.